Answers are grounded in this paper and cite their sources.
Case report demonstrates false-positive DOTATATE uptake across three distinct non-neuroendocrine lesions in an older adult, highlighting the necessity of histological confirmation.
Gallium-68 (⁶⁸Ga) DOTATATE positron emission tomography/computed tomography (PET/CT) has emerged as the gold standard imaging modality for neuroendocrine tumors (NETs). However, false-positive uptake in non-NET pathologies can be a diagnostic dilemma. The authors report a case of a 70-year-old woman presenting with recurrent small bowel obstructions, chronic diarrhea, and progressive weight loss. CT imaging demonstrated high-grade small bowel obstruction with marked bowel wall thickening and confluent mesenteric and retroperitoneal lymphadenopathy that had progressively increased over the prior year, raising clinical suspicion for NET. DOTATATE PET/CT revealed elevated uptake in the terminal ileum, mesenteric and retroperitoneal lymph nodes, and L4 vertebral body, a distribution that was suspicious for metastatic small bowel NET. However, tissue confirmation and correlation with anatomic imaging established 3 concurrent non-NET diagnoses: grade 3A follicular lymphoma, Crohn's disease, and a benign vertebral hemangioma. Simultaneous DOTATATE uptake in multiple distinct entities represents a diagnostic challenge requiring careful correlation of metabolic, anatomic, clinical, and pathologic data.
No takes yet. Share an insight, caveat, or question.
Khabaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: